triethanolamine has been researched along with Breast Neoplasms in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Behroozian, T; Beveridge, M; Bonomo, P; Caini, S; Chow, E; Fatima, S; Hirakawa, S; Lam, H; Marta, GN; Ryan Wolf, J; van den Hurk, C | 1 |
Carrie, C; D'Hombres, A; Gomez, F; Montbarbon, X; Pommier, P; Sunyach, MP | 1 |
Alfonsi, M; Allavena, C; Bastit, L; Boisseau, JM; De Rauglaudre, G; Faure, P; Levecq, JM; Miot, C; Ribet, V; Salas, S; Talon, B | 1 |
Andraos, T; Chehab, C; Eid, T; Geara, FB; Ramia, P; Thebian, R; Youssef, B; Zeidan, YH; Zouain, N | 1 |
Gosselin, TK; Plambeck, MA; Rowe, K; Schneider, SM | 1 |
Kost, T | 1 |
Aistars, J; Vehlow, K | 1 |
Ackerman, I; Andersson, L; Chow, E; Franssen, E; Hayter, C; Kim, J; Sixel, K; Szumacher, E; Tsao, M; Ung, Y; Wighton, A; Wojcicka, A | 1 |
1 review(s) available for triethanolamine and Breast Neoplasms
Article | Year |
---|---|
Topical non-steroidal agents for the prevention of radiation dermatitis: a systematic review and meta-analysis.
Topics: Breast Neoplasms; Ethanolamines; Female; Humans; Hyaluronic Acid; Radiodermatitis | 2023 |
5 trial(s) available for triethanolamine and Breast Neoplasms
Article | Year |
---|---|
Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Breast Neoplasms; Calendula; Combined Modality Therapy; Ethanolamines; Female; Humans; Middle Aged; Ointments; Plant Extracts; Radiation Injuries; Radiodermatitis; Radiotherapy, Adjuvant | 2004 |
[Interest of a sterilised anti-burning gel in radiation dermatitis: results of a comparative study].
Topics: Adult; Aged; Breast Neoplasms; Data Interpretation, Statistical; Dermatologic Agents; Erythema; Ethanolamines; Female; Gels; Humans; Male; Middle Aged; Mineral Waters; Ointments; Otorhinolaryngologic Neoplasms; Pruritus; Radiodermatitis; Time Factors; Treatment Outcome | 2008 |
Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Topics: Administration, Topical; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Dermatologic Agents; Disease Management; Emulsions; Female; Follow-Up Studies; Humans; Lipids; Middle Aged; Prognosis; Prospective Studies; Radiodermatitis; Radiotherapy; Sitosterols | 2018 |
A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy.
Topics: Breast Neoplasms; Dermatologic Agents; Double-Blind Method; Emulsions; Female; Gels; Humans; Lipids; Middle Aged; Ointments; Prospective Studies; Radiodermatitis; Skin Care; Treatment Outcome | 2010 |
Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Dermatologic Agents; Emulsions; Female; Humans; Lipids; Mastectomy, Segmental; Middle Aged; Outcome Assessment, Health Care; Radiodermatitis; Silver Sulfadiazine; Surveys and Questionnaires | 2001 |
2 other study(ies) available for triethanolamine and Breast Neoplasms
Article | Year |
---|---|
Information about Biafine for radiation dermatitis excluded important information.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cohort Studies; Cost-Benefit Analysis; Drug Approval; Drug Costs; Drug Evaluation; Emollients; Emulsions; Female; Humans; Lipids; Radiodermatitis; Treatment Outcome; United States | 2004 |
Radiation dermatitis.
Topics: Adult; Aloe; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Emulsions; Female; Follow-Up Studies; Humans; Lipids; Mastectomy, Segmental; Radiodermatitis; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Treatment Outcome; Ultrasonography | 2007 |